Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ZNF571 antisense RNA 1 (ZNF571-AS1) is a **long non-coding RNA (lncRNA)** that is transcribed in the antisense orientation relative to the ZNF571 gene on chromosome 19[13]. As an **antisense lncRNA**, ZNF571-AS1 does not encode a protein but likely regulates the expression of the neighboring zinc finger protein 571 (ZNF571) gene and potentially other targets through mechanisms such as modulation of mRNA stability, chromatin modification, and/or acting as a competing endogenous RNA[1][2][5][7]. Subcellular localization predictions suggest it is primarily found in the nucleus, consistent with roles in gene expression regulation and epigenetic modification[5]. Currently, ZNF571-AS1 is not a well-established therapeutic target (such as a receptor, enzyme, or transporter), nor are there any drugs known to directly interact with this molecule. However, its differential expression in cardiac diseases, particularly in patients with dilated cardiomyopathy, points to a possible biomarker role for disease status or response to hemodynamic interventions such as LVAD support[5]. Further functional research may clarify additional roles in human health and disease, but as of now, no direct disease associations (beyond biomarker status) or therapeutic implications have been conclusively demonstrated for ZNF571-AS1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ZNF571 antisense RNA 1 (ZNF571-AS1).